Highlights and Quick Summary
- Shareholders Equity per Share for the quarter ending June 30, 2023 was 3.46 (a -19.51% decrease compared to previous quarter)
- Year-over-year quarterly Shareholders Equity per Share decreased by -28.29%
- Annual Shareholders Equity per Share for 2022 was 4.86 (a -32.88% decrease from previous year)
- Annual Shareholders Equity per Share for 2021 was 7.23 (a -69.58% decrease from previous year)
- Annual Shareholders Equity per Share for 2020 was 23.78 (a 313.93% increase from previous year)
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Shareholders Equity per Share of Dyne Therapeutics, Inc.
Most recent Shareholders Equity per Shareof DYN including historical data for past 10 years.Interactive Chart of Shareholders Equity per Share of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Shareholders Equity per Share for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 3.46 | 4.3 | – | – | – |
| 2022 | 4.81 | 4.82 | 5.55 | 6.52 | 4.86 |
| 2021 | 7.23 | 8.07 | 8.84 | 9.67 | 7.23 |
| 2020 | 23.78 | 53.01 | 0.0 | 0.0 | 23.78 |
| 2019 | – | – | 0.0 | 0.0 | 5.75 |
| 2018 | – | – | – | – | 0.09 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology